Princess Margaret Hematology Conference (PMHC)

Princess Margaret Hematology Conference (PMHC) is organized by International Lymphoma Radiation Oncology Group (ILROG) and University Health Network (UHN) and will be held from Mar 26 - 28, 2026 at Courtyard by Marriott Toronto Downtown, Toronto, Ontario, Canada.

Description:

The Princess Margaret Hematology Conference (PMHC), held in collaboration with the International Lymphoma Radiation Oncology Group (ILROG), is a landmark inaugural event within the Malignant Hematology Program at the Princess Margaret Cancer Centre, one of the world’s leading cancer research and treatment institutions. This prestigious conference is designed to foster collaboration, innovation, and knowledge exchange among national and international experts, researchers, clinicians, and other professionals dedicated to advancing the field of hematologic malignancies, including leukemia, lymphoma, myeloma, and related disorders as well as the recent developments in allogeneic/ autologous hematopoietic stem cell transplantation and immune cellular therapy for the treatment of hematologic cancers.

This is a two and a half day scientific forum which aims to serve as a premier platform for discussing the latest advancements in clinical and basic research, as well as the development of cutting-edge clinical studies in hematologic cancers. By bringing together a diverse group of stakeholders—renowned oncologists, hematologists, radiation oncologists, researchers, translational scientists, and allied health professionals—the conference will facilitate interdisciplinary dialogue to address the most pressing challenges and opportunities in the field. This includes keynote speakers, plenary and breakout sessions, poster presentations, debate and networking opportunities at the welcome reception. 

The conference overall objectives are to:

• Present the latest breakthroughs in the understanding, diagnosis, and treatment of hematologic malignancies, including novel therapies, precision medicine, and immunotherapy.
• Create opportunities for networking and collaboration among global leaders to drive innovative clinical trials and research initiatives.
• Provide updates on evidence-based practices, emerging technologies, and multidisciplinary approaches to improve patient outcomes.
• Offer a platform for early-career researchers and clinicians to present their work, engage with experts, and contribute to the field’s future.